Table 5.

Proportion of Cases and Costs Identified for the Different Screening Strategies for a 25% Increase in Prevalence, a 25% Decrease in Prevalence, or Adult Prevalence Assumptions

Screening Strategy and Cutoff Value	Cases Identified, %	25% Increase in Prevalence		25% Decrease in Prevalence		Adult Prevalence Assumptions (8% for Diabetes and 37% for Prediabetes)
		Total Costs (Direct and Indirect), $	Cost per Case Identified (Direct and Indirect), $	Total Costs (Direct and Indirect), $	Cost per Case Identified (Direct and Indirect), $	Total Costs (Direct and Indirect), $	Cost per Case Identified (Direct and Indirect), $
Diabetes mellitus
2-h OGTT(200mg/dL)	100	156111876	249779	156111876	416298	156111876	781
HbAlc
5.5%	33	138513150	664 930	138514325	1108225	137576050	2064
5.7%	33	121958377	585459	121957896	975 761	122 341851	1835
6.5%	33	95216051	457 083	95 212895	761 779	97732 759	1466
Dysglycemia (prediabetes and diabetes)
2-hOGTT(140mg/dL)	100	156111876	312	156111876	520	156111876	169
Random glucose test
100mg/dL	55	110385806	401	108517621	658	114 355 700	225
110mg/dL	30	87245787	582	85 717272	952	90493 882	326
HbA1c
5.5%	45	137454618	611	137284783	1017	137815518	331
5.7%	32	120258824	752	119749319	1247	121341523	410
6.5%	7	94 571280	2702	94146693	4483	95 473 529	1474
1-h Glucose challenge test
110mg/dL	63	145118357	461	142 910502	756	149810049	257
120mg/dL	44	125 799626	572	123 676688	937	130310868	326

Abbreviations: HbA_1c hemoglobin A_1c; OGTT, oral glucose tolerance test.